These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4368009)

  • 1. The role of the first component of the bovine complement system in the haemolytic activity of a bovine derived lytic intermediate.
    Pang AS; Aston WP
    Life Sci; 1974 May; 14(10):1857-69. PubMed ID: 4368009
    [No Abstract]   [Full Text] [Related]  

  • 2. Haemolytic assay of bovine serum complement.
    Barta O; Barta V
    J Immunol Methods; 1972 Aug; 1(4):363-74. PubMed ID: 4218251
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune haemolysis: reaction of the terminal complement component.
    Götze O; Haupt I; Fischer H
    Nature; 1968 Mar; 217(5134):1165-7. PubMed ID: 4966850
    [No Abstract]   [Full Text] [Related]  

  • 4. Kinetics of bovine complement. II. Properties of the lytic intermediate.
    Fong JS; Muschel LH; Good RA
    J Immunol; 1971 Jul; 107(1):34-40. PubMed ID: 4997115
    [No Abstract]   [Full Text] [Related]  

  • 5. Kinetics of bovine complement. I. Formation of a lytic intermediate.
    Fong JS; Muschel LH; Good RA
    J Immunol; 1971 Jul; 107(1):28-33. PubMed ID: 5091959
    [No Abstract]   [Full Text] [Related]  

  • 6. Complement: optimal reaction conditions for guinea pig C4.
    Linscott WD
    J Immunol; 1973 Jul; 111(1):189-99. PubMed ID: 4197333
    [No Abstract]   [Full Text] [Related]  

  • 7. Complement: a reversible temperature-dependent alteration in the reactivity of EAC1 with C4.
    Linscott WD
    J Immunol; 1973 Jul; 111(1):200-11. PubMed ID: 4197334
    [No Abstract]   [Full Text] [Related]  

  • 8. Development and characterization of a hemolytic assay for mouse C4.
    Atkinson JP; McGinnis K; Shreffler D
    J Immunol Methods; 1980; 33(4):351-68. PubMed ID: 6768807
    [No Abstract]   [Full Text] [Related]  

  • 9. Canine hemolytic complement: optimal conditions for its titration.
    Barta O; Barta V
    Am J Vet Res; 1973 May; 34(5):653-7. PubMed ID: 4634064
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of zinc and cadmium on guinea-pig complement.
    Amiraian K; McKinney JA; Duchna L
    Immunology; 1974 Jun; 26(6):1135-44. PubMed ID: 4851716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-complement effects of two anti-inflammatory agents. Niflumic and flufenamic acids.
    Harrity TW; Goldlust MB
    Biochem Pharmacol; 1974 Nov; 23(22):3107-20. PubMed ID: 4216354
    [No Abstract]   [Full Text] [Related]  

  • 12. The first component of guinea pig complement: hemolytic assays with EA, EAC4 and with rat and guinea pig late acting components.
    Opferkuch W; Rapp HJ; Colten HR; Borsos T
    Immunochemistry; 1971 Jun; 8(6):517-23. PubMed ID: 4997463
    [No Abstract]   [Full Text] [Related]  

  • 13. Simple methods of rabbit hemolytic complement component assays.
    Lindorfer JF; Fong JS; Good RA
    Int Arch Allergy Appl Immunol; 1974; 46(4):539-51. PubMed ID: 4856448
    [No Abstract]   [Full Text] [Related]  

  • 14. Complement dependent hemolysis of sheep erythrocytes coupled with non-antibody human IgG.
    Inai S; Tsuyuguchi I
    Biken J; 1968 Dec; 11(4):261-7. PubMed ID: 4181155
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluid phase destruction of C2 hu by C1 hu. 3. Changes in activity for synthetic substrates upon cell binding, heat inactivation and interaction with C1INH.
    Kondo M; Gigli I; Austen KF
    Immunology; 1972 Mar; 22(3):305-18. PubMed ID: 5063623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the esterases of canine serum.
    Ecobichon DJ
    Can J Biochem; 1970 Dec; 48(12):1359-67. PubMed ID: 4995115
    [No Abstract]   [Full Text] [Related]  

  • 17. A new method for the preparation of EAC14 cell with human or guinea-pig serum.
    Nagaki K; Iida K; Inai S
    J Immunol Methods; 1974 Aug; 5(3):307-17. PubMed ID: 4610058
    [No Abstract]   [Full Text] [Related]  

  • 18. Antigenic relationship between the C4 inactivating substance produced by KB cell cultures and the first component of human complement (C1).
    Füst G; Kósa S
    Med Microbiol Immunol; 1972; 157(3):244-50. PubMed ID: 4625764
    [No Abstract]   [Full Text] [Related]  

  • 19. The nature of human Cl-esterase: its role in the complement reaction and the thermodynamic parameters associated with its action on some synthetic substrates.
    Westfall S; Wirtz GH; Canady WJ
    Immunochemistry; 1972 Dec; 9(12):1221-31. PubMed ID: 4675695
    [No Abstract]   [Full Text] [Related]  

  • 20. The inhibitory effect of 3-(3,4-dichlorophenoxyacetamido)-N-(3-chloro-2-fluorosulphonylbenzyl) pyridinium bromide on bovine complement.
    Pang AS; Schmidt DE; Aston WP
    Life Sci; 1973 Aug; 13(4):351-62. PubMed ID: 4796227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.